These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Physiopathology of schizophrenia. Some biologic aspects]. Tissot R Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787 [No Abstract] [Full Text] [Related]
4. Integrating the neurobiology of schizophrenia. Preface. Abi-Dargham A; Guillin O Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855 [No Abstract] [Full Text] [Related]
5. Antipsychotic drugs, neurotransmitters, and schizophrenia. Carlsson A Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684 [TBL] [Abstract][Full Text] [Related]
6. [A biochemical theory of schizophrenia]. Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120 [TBL] [Abstract][Full Text] [Related]
7. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Chesselet MF Neuroscience; 1984 Jun; 12(2):347-75. PubMed ID: 6146946 [No Abstract] [Full Text] [Related]
8. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. Stahl SM CNS Spectr; 2018 Jun; 23(3):187-191. PubMed ID: 29954475 [TBL] [Abstract][Full Text] [Related]
9. The serotonergic system in the brain and its possible functional connections with other aminergic systems. Samanin R; Garattini S Life Sci; 1975 Oct; 17(8):1201-9. PubMed ID: 574 [No Abstract] [Full Text] [Related]
10. Regulation of neurotransmitter reuptake by nitric oxide. Pögün S; Kuhar MJ Ann N Y Acad Sci; 1994 Nov; 738():305-15. PubMed ID: 7832440 [No Abstract] [Full Text] [Related]
11. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson ML Annu Rev Pharmacol Toxicol; 2001; 41():237-60. PubMed ID: 11264457 [TBL] [Abstract][Full Text] [Related]
12. Alterations of serotonin transmission in schizophrenia. Abi-Dargham A Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860 [TBL] [Abstract][Full Text] [Related]
13. [Biochemistry of schizophrenia and mechanism of action of neuroleptics]. Loo H; Cuche H; Sechter D Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604 [TBL] [Abstract][Full Text] [Related]
15. Alterations of dopamine and serotonin transmission in schizophrenia. Remington G Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030 [TBL] [Abstract][Full Text] [Related]
16. [The biology of schizophrenia: current status and perspectives of its knowledge]. Díaz JL Rev Invest Clin; 1986; 38(1):89-110. PubMed ID: 2874601 [No Abstract] [Full Text] [Related]
17. [Neurotransmitters in Huntington chorea (review)]. Barkhatova VP; Larskiĭ EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405 [No Abstract] [Full Text] [Related]
18. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. Amargós-Bosch M; Adell A; Artigas F J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545 [TBL] [Abstract][Full Text] [Related]
19. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development. Marek GJ Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861 [TBL] [Abstract][Full Text] [Related]
20. Schizophrenia: from dopaminergic to glutamatergic interventions. Laruelle M Curr Opin Pharmacol; 2014 Feb; 14():97-102. PubMed ID: 24524997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]